Phase II study of gemcitabine and cisplatin in women with taxane-failed metastatic breast cancer (MBC)

被引：0
|
作者：
Wang, T. [1 ]
Jiang, Z. [1 ]
Song, S. [1 ]
Shen, G. [1 ]
Zhang, S. [1 ]
Wu, S. [1 ]
Zeng, M. [1 ]
机构：
[1] 307 Hosp Affiliated, Mil Med Acad, Ctr Canc, Beijing, Peoples R China
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：127 / 127
页数：1
相关论文
共 50 条
  • [41] A phase II study of cisplatin and vinorelbine in patients with metastatic breast cancer
    Mustacchi, G
    Muggia, M
    Milani, S
    Ceccherini, R
    Leita, ML
    Dellach, C
    ANNALS OF ONCOLOGY, 2002, 13 (11) : 1730 - 1736
  • [42] Phase II study of gemcitabine plus cisplatin in patients with metastatic breast cancer - A north central cancer treatment group trial
    Burch, PA
    Mailliard, JA
    Hillman, DW
    Perez, EA
    Krook, JE
    Rowland, KM
    Veeder, MH
    Cannon, MW
    Ingle, JN
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (02): : 195 - 200
  • [43] Phase II gemcitabine and capecitabine combination therapy in recurrent or metastatic breast cancer patients pretreated with anthracycline and taxane
    Ji Soo Park
    Hei-Cheul Jeung
    Sun Young Rha
    Joong Bae Ahn
    Beodeul Kang
    Hong Jae Chon
    Min Hee Hong
    Seungtaek Lim
    Woo Ick Yang
    Chung Mo Nam
    Hyun Cheol Chung
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 799 - 808
  • [44] A clinical phase II study of cisplatin and vinorelbine followed by docetaxel as first-line treatment in metastatic breast cancer (MBC).
    Yassine, H
    Khalifeh, M
    Bitar, N
    Charafeddine, M
    Dheiny, M
    Chehal, A
    Jalloul, R
    Dandashi, A
    Wehbeh, M
    Shamseddine, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 83S - 83S
  • [45] A phase II study of oral MKC-1 for metastatic breast cancer (MBC)
    Schneider, B. P.
    Karwal, M.
    Laufman, L.
    Sylvester, L.
    Taylor, M. A.
    Sidor, C.
    Hannah, A.
    Arnott, J.
    Miller, K. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [46] Phase 2 study of MKC-1 in patients (pts) with metastatic breast cancer (MBC) who have failed prior therapy with an anthracycline (A) and taxane (T)
    Sylvester, L.
    Laufman, L.
    Jabboury, K.
    Saleh, M.
    Tkaczuk, K.
    Volterra, F.
    Arnott, J.
    Hannah, A.
    Sidor, C.
    Miller, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [47] Phase II study cisplatin plus gemcitabine (Gemzar) in antracycline, docetaxel and capecitabine-refractory metastatic breast cancer
    Semiglazova, Tatiana
    Filatova, Larisa
    ANNALS OF ONCOLOGY, 2004, 15 : 43 - 43
  • [48] A phase II study of pemetrexed and doxorubicin in patients with advanced or metastatic breast cancer (MBC)
    Blasinska-Morawiec, M.
    Martin, M.
    Salas, F.
    Falcon, S.
    Rolski, J.
    Ferrari, B. L.
    Guedez, N.
    Simms, L.
    Gulyas, S.
    Melemed, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [49] Gemcitabine plus cisplatin combination as second-line treatment in patients with metastatic breast cancer (MBC).
    Ajarim, D
    Ezzat, A
    Bazarbashi, S
    Rahal, M
    El Foudeh, M
    Pai, C
    Raja, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 70S - 70S
  • [50] Phase I/II study of gemcitabine in association with vinorelbine for metastatic breast cancer
    Mariani, G
    Tagliabue, P
    Zucchinelli, P
    Brambilla, C
    Demicheli, R
    Villa, E
    Marchianò, A
    Valagussa, P
    Bonadonna, G
    Gianni, L
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 70 (03) : 163 - 169
12345